Advanced

Dosing regimens, FVIII levels and estimated haemostatic protection with special focus on rFVIIIFc.

Berntorp, Erik LU ; Negrier, C; Gozzi, P; Blaas, P-M and Lethagen, S (2016) In Haemophilia
Abstract
To use Pharmacokinetic (PK) simulations to illustrate potential differences in clinical outcomes between prophylaxis with conventional recombinant factor VIII (rFVIII) and rFVIIIFc, an extended half-life rFVIII covalently fused to the Fc domain of human IgG1.
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Haemophilia
publisher
Federation of European Neuroscience Societies and Blackwell Publishing Ltd
external identifiers
  • pmid:26863900
  • scopus:84958279902
  • wos:000379715000035
ISSN
1351-8216
DOI
10.1111/hae.12887
language
English
LU publication?
yes
id
7bf7d164-1e29-4fee-8a80-c0d312ba47d7 (old id 8825865)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/26863900?dopt=Abstract
date added to LUP
2016-03-03 09:39:53
date last changed
2017-11-12 04:06:21
@article{7bf7d164-1e29-4fee-8a80-c0d312ba47d7,
  abstract     = {To use Pharmacokinetic (PK) simulations to illustrate potential differences in clinical outcomes between prophylaxis with conventional recombinant factor VIII (rFVIII) and rFVIIIFc, an extended half-life rFVIII covalently fused to the Fc domain of human IgG1.},
  author       = {Berntorp, Erik and Negrier, C and Gozzi, P and Blaas, P-M and Lethagen, S},
  issn         = {1351-8216},
  language     = {eng},
  month        = {02},
  publisher    = {Federation of European Neuroscience Societies and Blackwell Publishing Ltd},
  series       = {Haemophilia},
  title        = {Dosing regimens, FVIII levels and estimated haemostatic protection with special focus on rFVIIIFc.},
  url          = {http://dx.doi.org/10.1111/hae.12887},
  year         = {2016},
}